Bayer Loses Fight Over Chemicals EU Blamed for Killing Bees
(Bloomberg) -- Bayer AG lost its fight to topple a European Union ban on controversial insecticides that regulators blame for killing honeybees.
The EU Court of Justice dismissed the appeal, finding there were no legal errors in the European Commission's decision to impose restrictions on the substances' use, based on concerns that the chemicals posed “high acute risks for bees” and “the survival and development of colonies in several crops.”
Bayer and Syngenta AG in 2018 already lost a first round in court after telling judges that the EU ban on three so-called neonicotinoids forced farmers to revert to potentially more harmful chemicals. Bayer appealed one more time.
The EU's decision five years earlier imposed limits on the use of three neonics -- clothianidin, imidacloprid and thiametoxam -- saying they were “harmful” to Europe's honeybee population when used to treat flowering plants with nectar that attracts the insects.
The court ruled on Thursday the commission “is entitled to consider that a risk to the colonies could not be ruled out” even if there is “scientific uncertainty at this stage as to the rate of mortality of individual bees.”
EU governments in 2018 voted in favor of widening the ban of neonicotinoids to apply everywhere, except for greenhouses. The commission has described the chemicals as “systemic,” causing the entire plant to become toxic to bees.
Bayer said in an emailed statement that Thursday's ruling “seems to allow the commission almost carte blanche to review existing approvals upon the slightest evidence, which need not even be new scientific data.”
The company said it accepts the 2018 decision to broadly restrict the use of certain neonicotinoids in agriculture, but that it “stands by the safety of its products -- which have been approved by regulatory bodies around the globe -- and reiterates the value that these products have for farmers in managing pests effectively.”
France, the EU's top sugar exporter, last year partially lifted a ban on neonicotinoids by allowing its use for seed coatings for three years through 2023 after farmers suffered heavy losses from beet yellows virus spread by aphids that neonicotinoids help control.
The European Food Safety Authority in December said it will assess 21 emergency authorizations by EU nations to use neonicotinoids for sugar beet crop.
The case is: C‑499/18 P, Bayer CropScience AG and Bayer AG v. European Commission.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.